It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Japanese biotech firm uses tiny worms in test for pancreatic cancer

Business / Corporate Nov 30, 2022

Japanese biotech firm uses tiny worms in test for pancreatic cancer

by Rocky Swift

The creatures, a species of nematodes known scientifically as C. elegans, have olfactory senses much more powerful than dogs, the firm says, and they follow their nose toward cancer cells.

Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge

Business Nov 30, 2022

Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge

by Robert Langreth

The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.

Scientists revive 48,500-year-old ‘zombie virus’ buried in ice

World / Science & Health Nov 29, 2022

Scientists revive 48,500-year-old ‘zombie virus’ buried in ice

Scientists have long warned that the thawing of permafrost due to atmospheric warming will worsen climate change. But its effect on dormant pathogens is less well understood.

Eisai and Biogen plunge after report of second death in Alzheimer’s trial

Business / Financial Markets Nov 29, 2022

Eisai and Biogen plunge after report of second death in Alzheimer’s trial

by Naomi Kresge

The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.

Researchers test mRNA technology for universal flu vaccine

World / Science & Health Nov 25, 2022

Researchers test mRNA technology for universal flu vaccine

by Nancy Lapid

A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.

Shionogi applies for COVID-19 vaccine approval, would be first Japan-made

National / Science & Health Nov 24, 2022

Shionogi applies for COVID-19 vaccine approval, would be first Japan-made

The recombinant protein-based preventive vaccine is the same type as a COVID-19 vaccine developed by Novavax and differs from messenger RNA vaccines developed by Pfizer or Moderna.

TV dramas leading more young people into forensics

National Nov 22, 2022

TV dramas leading more young people into forensics

by Koga Hirouchi

Senior forensic doctors are welcoming the movement as a "bright sign" for the future of the practice, which has often been marginalized.

Pfizer’s RSV vaccine succeeds where others failed

Commentary / World Nov 21, 2022

Pfizer’s RSV vaccine succeeds where others failed

by Lisa Jarvis

Early data bodes well for Pfizer’s RSV shot, which would be given during pregnancy to protect infants in the early months of life.

Why China won't cooperate on finding the origins of COVID-19

Commentary / World Nov 18, 2022

Why China won't cooperate on finding the origins of COVID-19

by Matthew Fulco

For Beijing, winning its ‘people’s war’ against the coronavirus by controlling the propaganda narrative is more important than learning the truth about the pandemic.

New weight-loss drugs work, but who's paying?

Commentary / World Nov 16, 2022

New weight-loss drugs work, but who's paying?

by Lisa Jarvis

Novo Nordisk and Eli Lilly say they can treat obesity with a weekly injection. But insurers aren’t yet on board.

Why China won’t end its 'COVID zero' policy

Commentary / World Nov 15, 2022

Why China won’t end its 'COVID zero' policy

by Matthew Fulco

Chinese President Xi Jinping early on took ownership of the battle against the coronavirus — now his political legitimacy rests on the outcome.

If you’ve had COVID-19, watch out for stroke symptoms

Commentary / World Nov 14, 2022

If you’ve had COVID-19, watch out for stroke symptoms

by Faye Flam

Several studies now show an elevated risk of serious blood vessel inflammation during and after an infection.

« 1 … 9 10 11 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times